Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for P81021

Entry ID Method Resolution Chain Position Source
AF-P81021-F1 Predicted AlphaFoldDB

No variants for P81021

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for P81021

No associated diseases with P81021

28 regional properties for P81021

Type Name Position InterPro Accession
domain K Homology domain 148 - 216 IPR004087-1
domain K Homology domain 220 - 288 IPR004087-2
domain K Homology domain 293 - 361 IPR004087-3
domain K Homology domain 362 - 428 IPR004087-4
domain K Homology domain 433 - 501 IPR004087-5
domain K Homology domain 505 - 574 IPR004087-6
domain K Homology domain 579 - 648 IPR004087-7
domain K Homology domain 652 - 725 IPR004087-8
domain K Homology domain 726 - 795 IPR004087-9
domain K Homology domain 799 - 869 IPR004087-10
domain K Homology domain 873 - 973 IPR004087-11
domain K Homology domain 974 - 1041 IPR004087-12
domain K Homology domain 1053 - 1124 IPR004087-13
domain K Homology domain 1128 - 1197 IPR004087-14
domain K Homology domain, type 1 153 - 212 IPR004088-1
domain K Homology domain, type 1 224 - 284 IPR004088-2
domain K Homology domain, type 1 297 - 356 IPR004088-3
domain K Homology domain, type 1 367 - 424 IPR004088-4
domain K Homology domain, type 1 438 - 497 IPR004088-5
domain K Homology domain, type 1 511 - 570 IPR004088-6
domain K Homology domain, type 1 583 - 644 IPR004088-7
domain K Homology domain, type 1 656 - 704 IPR004088-8
domain K Homology domain, type 1 735 - 791 IPR004088-9
domain K Homology domain, type 1 804 - 866 IPR004088-10
domain K Homology domain, type 1 877 - 969 IPR004088-11
domain K Homology domain, type 1 975 - 1036 IPR004088-12
domain K Homology domain, type 1 1057 - 1120 IPR004088-13
domain K Homology domain, type 1 1133 - 1193 IPR004088-14

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
polysome A multiribosomal structure representing a linear array of ribosomes held together by messenger RNA. They represent the active complexes in cellular protein synthesis and are able to incorporate amino acids into polypeptides both in vivo and in vitro.

1 GO annotations of molecular function

Name Definition
mRNA binding Binding to messenger RNA (mRNA), an intermediate molecule between DNA and protein. mRNA includes UTR and coding sequences, but does not contain introns.

No GO annotations of biological process

Name Definition
No GO annotations for biological process

5 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q24009 BicC Protein bicaudal C Drosophila melanogaster (Fruit fly) PR
Q00341 HDLBP Vigilin Homo sapiens (Human) PR
Q8VDJ3 Hdlbp Vigilin Mus musculus (Mouse) PR
Q9Z1A6 Hdlbp Vigilin Rattus norvegicus (Rat) PR
P34307 C06G4.1 KH domain-containing protein C06G4.1 Caenorhabditis elegans PR
10 20 30 40 50 60
MSSVAVLTQE SFAEHRSGLT QQQVKVTALN SEEENDPPTY KEAFPPLPEK APCLEAAQEP
70 80 90 100 110 120
SGPWSKIRPI KASVITQVFH VPLEERKYKD MNQFGEGEQA KICLDIMQKT GAHLELSLAK
130 140 150 160 170 180
DQGLSIMVSG KLEAVMKARK EIVARLQTQA SATVAIPKEH HRFVIGKNGE KLQDLELKTA
190 200 210 220 230 240
TKIQIPRPDD PSNQIKITGT KEGIEKARHE ILLISAEQDK RAVERLDVEK VYHPFIAGPY
250 260 270 280 290 300
NKLVSELMQD TGTRINIPPP SVNKTEIVFT GEKEQLAQAV ARVKKIYEEK KKKTTTIAVE
310 320 330 340 350 360
VKKSQHKYVI GRKGNSLQEI LEKTGVSVEI PPTDSSSETV ILRGEPEKLG QALTEVYAKA
370 380 390 400 410 420
NSFTVSSVSA PSWLHRFIIG LFGQNLAKIT QQMPKIHIEF TEGEDKITSE GPTEDVNVAQ
430 440 450 460 470 480
EQIEVMVKDL INRTDYAEIN VDHKFHRHLI GKNGANINRI KDLYKVSVRI PPDNEKSNLI
490 500 510 520 530 540
RIEGDPQGVQ QAKKELLELA SRMENERTKD LIIEQKFHRT IIGQKGERIR EIREKFPEVI
550 560 570 580 590 600
INFPDPAHKS DIVQLRGPKN EVEKCTKYMQ KMVADLVENS FSISVPIFKQ FHKNIIGKGG
610 620 630 640 650 660
ANIKKIREES NTKIDLPGRE QATQRQLLSQ GREQTVKLLR HRILAIQKEL ANITEVEVSI
670 680 690 700 710 720
PSKLHNSLIG AKGRFIRSIM EECGGVHIHF PTEGSGSATV TIRAQPRTWR KPRSSCCTWA
730 740 750 760 770 780
EEKQTKSYTV DLRAKPEYHK FLIGKGGGNI RKVRDNTGAR IIFPTSEDKD QELITIMGTE
790 800 810 820 830 840
EAVKEAQKEL EALIKNLDNV VEDSMVVDPK HHRHFVIRRG QVLREIADEY GGVMVRLPTV
850 860 870 880 890 900
SGTQSDKVTL KGAKDCVEAA KKRIQEIIED LEAQVTIECT IPQKFHRSIM GPKGSRIQQI
910 920 930 940 950 960
TRDYGVQIKF PDREENPAPV AEPALQENGE EGGEGKDGKD ADPSSPRKCD IIIISGRREK
970 980 990 1000 1010 1020
CEAAKEALQA LVPVTIEVEV PFDLHRYIIG QKGSGIRKMM DEFEVNIQVP APELQSSDII
1030 1040 1050 1060 1070 1080
TITGLAANLD RAKAGLLERV KELQAEQEDR ALRSFKLTVT VDPKYHPKII GRKGAVITQI
1090 1100 1110 1120 1130 1140
RTEHEVNIQF PDKDDESQAQ DQITITGYEK NAEAARDAIM KIVGELEQMV SEDVTLDHRV
1150 1160 1170 1180 1190 1200
HARIIGARGK AIRKIMDEFK VDIRFPQSGA PDPNCVTVTG LPENVEEAID HILNLEEEYL
1210 1220 1230 1240 1250 1260
ADVVDNEAMQ VYMKPSSHEE SKVPSKGFVV RDAPCGTVNN EKAPDMSSSE DFPSFGAQVA
PKTLPWGPKR